Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Nifedipine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Nifedipine market. Detailed analysis of key players, along with key growth strategies adopted by Nifedipine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Shyndec (China)
Teva (Israel)
Honglin (China)
Bayer (Germany)
Yabao (China)
Actavis (USA)
Huanghai (China)
Pfizer (USA)
By Type:
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
By End-User:
Primary Pulmonary Hypertension
Heart Failure
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Nifedipine Market
-
1.3 Market Segment by Type
-
1.3.1 China Nifedipine Market Size and Growth Rate of Nifedipine Controlled Release Tablets from 2016 to 2027
-
1.3.2 China Nifedipine Market Size and Growth Rate of Nifedipine Extended Action Tablets from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Nifedipine Market Size and Growth Rate of Primary Pulmonary Hypertension from 2016 to 2027
-
1.4.2 China Nifedipine Market Size and Growth Rate of Heart Failure from 2016 to 2027
-
1.4.3 China Nifedipine Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Nifedipine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Nifedipine by Major Types
-
3.4.1 Market Size and Growth Rate of Nifedipine Controlled Release Tablets
-
3.4.2 Market Size and Growth Rate of Nifedipine Extended Action Tablets
4 Segmentation of Nifedipine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Nifedipine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Nifedipine in Primary Pulmonary Hypertension
-
4.4.2 Market Size and Growth Rate of Nifedipine in Heart Failure
-
4.4.3 Market Size and Growth Rate of Nifedipine in Others
5 Market Analysis by Regions
-
5.1 China Nifedipine Production Analysis by Regions
-
5.2 China Nifedipine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Nifedipine Landscape Analysis
-
6.1 North China Nifedipine Landscape Analysis by Major Types
-
6.2 North China Nifedipine Landscape Analysis by Major End-Users
7 Central China Nifedipine Landscape Analysis
-
7.1 Central China Nifedipine Landscape Analysis by Major Types
-
7.2 Central China Nifedipine Landscape Analysis by Major End-Users
8 South China Nifedipine Landscape Analysis
-
8.1 South China Nifedipine Landscape Analysis by Major Types
-
8.2 South China Nifedipine Landscape Analysis by Major End-Users
9 East China Nifedipine Landscape Analysis
-
9.1 East China Nifedipine Landscape Analysis by Major Types
-
9.2 East China Nifedipine Landscape Analysis by Major End-Users
10 Northeast China Nifedipine Landscape Analysis
-
10.1 Northeast China Nifedipine Landscape Analysis by Major Types
-
10.2 Northeast China Nifedipine Landscape Analysis by Major End-Users
11 Southwest China Nifedipine Landscape Analysis
-
11.1 Southwest China Nifedipine Landscape Analysis by Major Types
-
11.2 Southwest China Nifedipine Landscape Analysis by Major End-Users
12 Northwest China Nifedipine Landscape Analysis
-
12.1 Northwest China Nifedipine Landscape Analysis by Major Types
-
12.2 Northwest China Nifedipine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Shyndec (China)
-
13.1.1 Shyndec (China) Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Teva (Israel)
-
13.2.1 Teva (Israel) Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Honglin (China)
-
13.3.1 Honglin (China) Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Bayer (Germany)
-
13.4.1 Bayer (Germany) Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Yabao (China)
-
13.5.1 Yabao (China) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Actavis (USA)
-
13.6.1 Actavis (USA) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Huanghai (China)
-
13.7.1 Huanghai (China) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Pfizer (USA)
-
13.8.1 Pfizer (USA) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Nifedipine Market Size and Growth Rate of Nifedipine Controlled Release Tablets from 2016 to 2027
-
Figure China Nifedipine Market Size and Growth Rate of Nifedipine Extended Action Tablets from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Nifedipine Market Size and Growth Rate of Primary Pulmonary Hypertension from 2016 to 2027
-
Figure China Nifedipine Market Size and Growth Rate of Heart Failure from 2016 to 2027
-
Figure China Nifedipine Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Nifedipine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Nifedipine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Nifedipine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Nifedipine by Different Types from 2016 to 2027
-
Table Consumption Share of Nifedipine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Nifedipine Controlled Release Tablets
-
Figure Market Size and Growth Rate of Nifedipine Extended Action Tablets
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Nifedipine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Nifedipine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Primary Pulmonary Hypertension
-
Figure Market Size and Growth Rate of Heart Failure
-
Figure Market Size and Growth Rate of Others
-
Table China Nifedipine Production by Regions
-
Table China Nifedipine Production Share by Regions
-
Figure China Nifedipine Production Share by Regions in 2016
-
Figure China Nifedipine Production Share by Regions in 2021
-
Figure China Nifedipine Production Share by Regions in 2027
-
Table China Nifedipine Consumption by Regions
-
Table China Nifedipine Consumption Share by Regions
-
Figure China Nifedipine Consumption Share by Regions in 2016
-
Figure China Nifedipine Consumption Share by Regions in 2021
-
Figure China Nifedipine Consumption Share by Regions in 2027
-
Table North China Nifedipine Consumption by Types from 2016 to 2027
-
Table North China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure North China Nifedipine Consumption Share by Types in 2016
-
Figure North China Nifedipine Consumption Share by Types in 2021
-
Figure North China Nifedipine Consumption Share by Types in 2027
-
Table North China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table North China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Nifedipine Consumption Share by End-Users in 2016
-
Figure North China Nifedipine Consumption Share by End-Users in 2021
-
Figure North China Nifedipine Consumption Share by End-Users in 2027
-
Table Central China Nifedipine Consumption by Types from 2016 to 2027
-
Table Central China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure Central China Nifedipine Consumption Share by Types in 2016
-
Figure Central China Nifedipine Consumption Share by Types in 2021
-
Figure Central China Nifedipine Consumption Share by Types in 2027
-
Table Central China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table Central China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Nifedipine Consumption Share by End-Users in 2016
-
Figure Central China Nifedipine Consumption Share by End-Users in 2021
-
Figure Central China Nifedipine Consumption Share by End-Users in 2027
-
Table South China Nifedipine Consumption by Types from 2016 to 2027
-
Table South China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure South China Nifedipine Consumption Share by Types in 2016
-
Figure South China Nifedipine Consumption Share by Types in 2021
-
Figure South China Nifedipine Consumption Share by Types in 2027
-
Table South China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table South China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Nifedipine Consumption Share by End-Users in 2016
-
Figure South China Nifedipine Consumption Share by End-Users in 2021
-
Figure South China Nifedipine Consumption Share by End-Users in 2027
-
Table East China Nifedipine Consumption by Types from 2016 to 2027
-
Table East China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure East China Nifedipine Consumption Share by Types in 2016
-
Figure East China Nifedipine Consumption Share by Types in 2021
-
Figure East China Nifedipine Consumption Share by Types in 2027
-
Table East China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table East China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Nifedipine Consumption Share by End-Users in 2016
-
Figure East China Nifedipine Consumption Share by End-Users in 2021
-
Figure East China Nifedipine Consumption Share by End-Users in 2027
-
Table Northeast China Nifedipine Consumption by Types from 2016 to 2027
-
Table Northeast China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Nifedipine Consumption Share by Types in 2016
-
Figure Northeast China Nifedipine Consumption Share by Types in 2021
-
Figure Northeast China Nifedipine Consumption Share by Types in 2027
-
Table Northeast China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Nifedipine Consumption Share by End-Users in 2016
-
Figure Northeast China Nifedipine Consumption Share by End-Users in 2021
-
Figure Northeast China Nifedipine Consumption Share by End-Users in 2027
-
Table Southwest China Nifedipine Consumption by Types from 2016 to 2027
-
Table Southwest China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Nifedipine Consumption Share by Types in 2016
-
Figure Southwest China Nifedipine Consumption Share by Types in 2021
-
Figure Southwest China Nifedipine Consumption Share by Types in 2027
-
Table Southwest China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Nifedipine Consumption Share by End-Users in 2016
-
Figure Southwest China Nifedipine Consumption Share by End-Users in 2021
-
Figure Southwest China Nifedipine Consumption Share by End-Users in 2027
-
Table Northwest China Nifedipine Consumption by Types from 2016 to 2027
-
Table Northwest China Nifedipine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Nifedipine Consumption Share by Types in 2016
-
Figure Northwest China Nifedipine Consumption Share by Types in 2021
-
Figure Northwest China Nifedipine Consumption Share by Types in 2027
-
Table Northwest China Nifedipine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Nifedipine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Nifedipine Consumption Share by End-Users in 2016
-
Figure Northwest China Nifedipine Consumption Share by End-Users in 2021
-
Figure Northwest China Nifedipine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Shyndec (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shyndec (China)
-
Figure Sales and Growth Rate Analysis of Shyndec (China)
-
Figure Revenue and Market Share Analysis of Shyndec (China)
-
Table Product and Service Introduction of Shyndec (China)
-
Table Company Profile and Development Status of Teva (Israel)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva (Israel)
-
Figure Sales and Growth Rate Analysis of Teva (Israel)
-
Figure Revenue and Market Share Analysis of Teva (Israel)
-
Table Product and Service Introduction of Teva (Israel)
-
Table Company Profile and Development Status of Honglin (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Honglin (China)
-
Figure Sales and Growth Rate Analysis of Honglin (China)
-
Figure Revenue and Market Share Analysis of Honglin (China)
-
Table Product and Service Introduction of Honglin (China)
-
Table Company Profile and Development Status of Bayer (Germany)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer (Germany)
-
Figure Sales and Growth Rate Analysis of Bayer (Germany)
-
Figure Revenue and Market Share Analysis of Bayer (Germany)
-
Table Product and Service Introduction of Bayer (Germany)
-
Table Company Profile and Development Status of Yabao (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yabao (China)
-
Figure Sales and Growth Rate Analysis of Yabao (China)
-
Figure Revenue and Market Share Analysis of Yabao (China)
-
Table Product and Service Introduction of Yabao (China)
-
Table Company Profile and Development Status of Actavis (USA)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis (USA)
-
Figure Sales and Growth Rate Analysis of Actavis (USA)
-
Figure Revenue and Market Share Analysis of Actavis (USA)
-
Table Product and Service Introduction of Actavis (USA)
-
Table Company Profile and Development Status of Huanghai (China)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Huanghai (China)
-
Figure Sales and Growth Rate Analysis of Huanghai (China)
-
Figure Revenue and Market Share Analysis of Huanghai (China)
-
Table Product and Service Introduction of Huanghai (China)
-
Table Company Profile and Development Status of Pfizer (USA)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (USA)
-
Figure Sales and Growth Rate Analysis of Pfizer (USA)
-
Figure Revenue and Market Share Analysis of Pfizer (USA)
-
Table Product and Service Introduction of Pfizer (USA)
-
